Abstract
High resolution RP-HPLC method has been developed for the simultaneous determination of aspirin, Atenolol, Losartan Potassium and Atorvastatin in pharmaceutical dosage forms. HPLC analysis was carried out by using a X-Terra RP-18, 150×4.6mm, 5micron column with the gradient mobile phase composed of Sol-A: ammonium acetate buffer (1.4g of ammonium acetate in to 1000ml of HPLC water) and sol-B: acetonitrile with simple gradient program (0-4min, sol-A:98-92; 4-8min- sol-A:92-60; 8-13min- sol-A:60-65; 13-15min- sol-A:65-98 and 15-20min- sol-A:98-98). 1.0ml per min flow rate, 40°C column oven temperature and 230nm was selected for this study. The retention times of Aspirin, Atenolol, Losartan and Atorvastatin were 2.0min, 4.7min, 10.0min and 11.8min, respectively. Percent relative standard deviation for five replicate standard injections area is below 1.5percent. Validated the method with specificity, precision, linearity, accuracy, ruggedness and robustness. The response was linear over the concentration range of 10 to 60 μg per mL for each ingredient, with correlation coefficients value is greater than 0.999. Recovery results were between 98.0% to 102.0%. The developed method has applicable for regular analysis.
AVF shortcode render error: Layout is missing (avf-layout name="Article Addons" view-id="66d98451c48e3")